CBER Director Peter Marks (Greg Nash/Pool via AP Images)
April 18, 2023 02:57 PM EDT
Pharma
FDA+
Coronavirus

FDA sim­pli­fies Covid-19 bi­va­lent vac­ci­na­tion process ahead of June ad­comm

Paul Schloesser

Associate Editor

The FDA is mod­i­fy­ing the emer­gency use au­tho­riza­tion for Mod­er­na and Pfiz­er/BioN­Tech’s Covid-19 vac­cines by re­mov­ing the two-dose pri­ma­ry se­ries (ex­cept for chil­dren) and the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times